<DOC>
	<DOCNO>NCT03070522</DOCNO>
	<brief_summary>This 3 year randomize , double blind , placebo control trial 7 day oral prednisone cystic fibrosis ( CF ) patient receive intravenous ( IV ) antibiotic treatment pulmonary exacerbation Hospital Sick Children , St Michael 's Hospital , St Paul 's Hospital , British Columbia Children 's Hospital , Hotel Dieu Hospital Ste Justine Hospital , Canada . The intervention oral prednisone 2 mg/kg/day ( max 60 mg ) divide twice daily 7 day adjunctive therapy pulmonary exacerbation CF patient recover baseline force expiratory volume 1 second ( FEV1 ) 7 day IV antibiotic treatment . The primary outcome proportion subject achieve &gt; 90 % baseline FEV1 % predict day 14 IV antibiotic treatment pulmonary exacerbation treatment arm .</brief_summary>
	<brief_title>Prednisone Cystic Fibrosis Pulmonary Exacerbations</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>1 . Diagnosis CF newborn screen least one clinical feature CF , AND either ( ) ( b ) follow : 2 . A documented sweat chloride â‰¥ 60 mEq/L quantitative pilocarpine iontophoresis 3 . A genotype two identifiable CFcausing mutation 4 . Age &gt; 6 year old . 5 . Acute pulmonary exacerbation treat IV antibiotic previously define 10 % relative drop FEV1 baseline time exacerbation 6 . Informed consent patient parent/legal guardian 7 . Ability reproducibly perform pulmonary function test 8 . Ability comply medication use include ability take capsule , study visit study procedure judge site investigator 1 . A respiratory tract culture positive Burkholderia cenocepacia 12 month prior enrollment 2 . A respiratory tract culture positive Mycobacterium abscessus 12 month prior enrollment 3 . Treatment IV oral corticosteroid within 2 week enrollment 4 . Active allergic bronchopulmonary aspergillosis ( ABPA ) time enrollment determine treat physician 5 . Asthma related exacerbation enrollment define treat physician base clinically compatible symptom ( eg . wheeze ) 6 . Diabetes insulin time exacerbation 7 . History avascular necrosis pathologic bone fracture 8 . Uncontrolled hypertension end organ damage 9 . Active gastrointestinal bleeding 10 . Status post lung organ transplantation 11 . Pregnancy 12 . Lactose intolerance ( contain placebo ) 13 . Investigational drug use within 30 day prior enrollment visit 14 . Physical finding would compromise safety subject quality study data determine site investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>